Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.2.7 (
heparinase
)
1,270
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chronic inflammation is characterized by tissue infiltration with monocytes/macrophages, which possess broad proinflammatory, destructive, and remodeling capacities. Elevated levels of
osteoprotegerin
, an important regulator of differentiation and activation of osteoclasts that also affects different cells of the immune system, were found in the serum of patients with chronic inflammatory diseases. The study of whether
osteoprotegerin
affects monocyte locomotion in vitro and the possible mechanisms and pathways involved was investigated using Boyden microchemotaxis chambers and Western blot analyses.
Osteoprotegerin
significantly stimulated monocyte chemotaxis, whereas preincubation of monocytes with
osteoprotegerin
inhibited monocyte migration toward optimal concentrations of regulated upon activation normal T cell expressed and secreted, monocyte chemotactic protein -1, and procalcitonin. The effects of
osteoprotegerin
were abolished by pretreating cells with
heparinase
I and chondroitinase or antibodies against the ectodomain of syndecan-1.
Osteoprotegerin
signaling was shown to involve protein kinase C, phosphatidylinositol 3-kinase/Akt, and tyrosine kinase. Data suggest that
osteoprotegerin
affects monocyte mi-gration and protein kinase C and phosphatidylinositol 3-kinase/Akt activation via syndecan-1.
Osteoprotegerin
-induced deactivation of monocyte chemotaxis toward different chemokines is due to interaction of
osteoprotegerin
with heparan sulfate and chondroitin sulfate.
...
PMID:Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes. 1572 9